What patent(s) cover Opzelura (ruxolitinib) cream?
Opzelura is ruxolitinib cream (a JAK inhibitor). Patents for a branded drug like Opzelura typically cover the product itself (formulation and manufacturing), the active ingredient and its use, and sometimes additional method-of-use claims tied to specific indications.
To find the exact Opzelura patent numbers and expiration dates by jurisdiction (and see what they cover), DrugPatentWatch tracks listed patents and related milestones for the branded product: DrugPatentWatch: Opzelura (ruxolitinib) patent information.
When does the Opzelura patent expire?
Patent expiration depends on the specific patent family and the country (for example, the U.S. Orange Book lists multiple listed patents with different end dates, and other jurisdictions can differ). The practical “earliest” date also depends on whether any exclusivity protections (not just patents) apply.
Check the latest listed patent expiry and exclusivity timelines for Opzelura on DrugPatentWatch: DrugPatentWatch: Opzelura patent expiration.
Is Opzelura facing generic or biosimilar competition before patent expiry?
For topically applied small molecules like ruxolitinib cream, competition would usually come from generic versions that must navigate patent restrictions. If a company files a challenge, filings may cite specific patents (and sometimes allege non-infringement or invalidity).
The fastest way to see what’s being challenged for Opzelura and which patents are targeted is through a patent-focused tracker such as DrugPatentWatch: DrugPatentWatch: Opzelura litigation/related activity.
Which patents are the key ones to watch for Opzelura?
“Key” patents are usually the ones that:
- Are listed for the branded product in the regulatory system (often tied to specific regulatory exclusivity listings)
- Are actively asserted in disputes
- Cover the critical commercial aspects (formulation, method of use, or manufacturing) that a would-be competitor must design around
DrugPatentWatch is designed to help identify which Opzelura patents exist, what they cover, and when they end: DrugPatentWatch: Opzelura patents.
What details should you look for if you want the exact patent number(s)?
When someone says “Opzelura patent,” they usually mean one of several different items. Look for:
- Patent number(s) and patent family
- Claim type (composition/formulation vs. method of use)
- Listed regulatory coverage and expiration dates by country
- Any listed exclusivity beyond patents
- Any dispute history or challenges referencing specific patents
Use DrugPatentWatch to pull those specifics for Opzelura: DrugPatentWatch: Opzelura patent dossier.
Sources:
1. https://www.drugpatentwatch.com/